World-renowned physician, Dr. Michael Roizen, MD, continues to update your understanding of the meaning of health by providing an in-depth review of the most impactful health headlines. He discusses the health news that matters most to you.
Dr. Roizen is later joined by Dr. Naren Ramakrishna, director of neurologic and pediatric radiation oncology at UF Health Cancer Center in Orlando, Florida. Dr. Ramakrishna explains why proton therapy is the best solution for some people with brain or spinal cord tumors, how it works, and what it means for the future of cancer treatment.
Learn more about this fascinating advancement that has shown promise in treating several kinds of cancer.
Bonus!
Real Age Tip
Can Calcium Help Your Heart?
Selected Podcast
Hour 1: YOU The Owner's Manual Radio 7.9.16
Featuring:
Naren R. Ramakrishna, MD, PhD, is director of neurologic and pediatric radiation oncology at UF Health Cancer Center Orlando Health, and director of proton therapy at UF Health Cancer Center Orlando Health.
Dr. Ramakrishna received his bachelor’s degree in biology at The Johns Hopkins University, and his medical degree through the Medical Scientist Training Program at Cornell University’s Weill Cornell Medical College. He earned a doctorate in cell biology and genetics from the Weill Cornell Graduate School of Medical Sciences.
Naren R. Ramakrishna, MD, PhD
Naren R. Ramakrishna, MD, PhD, is director of neurologic and pediatric radiation oncology at UF Health Cancer Center Orlando Health, and director of proton therapy at UF Health Cancer Center Orlando Health.Dr. Ramakrishna received his bachelor’s degree in biology at The Johns Hopkins University, and his medical degree through the Medical Scientist Training Program at Cornell University’s Weill Cornell Medical College. He earned a doctorate in cell biology and genetics from the Weill Cornell Graduate School of Medical Sciences.
After an internal medicine internship at Mount Sinai Hospital, he completed a residency in radiation oncology at The Johns Hopkins Hospital, where he was chief resident. He also completed a Koch Research Fellowship in gene therapy and received an American Association for Cancer Research-Glaxo Wellcome Oncology Scholar Award.
Dr. Ramakrishna served for eight years on the faculty of Harvard Medical School as an instructor in radiation oncology. He was also chief of central nervous system radiation oncology at Dana-Farber/Brigham and Women’s Cancer Center and director of the CNS Radiation Oncology Fellowship Program. He is a diplomate of both the United States Medical Licensing Examination and the American Board of Radiology.
Dr. Ramakrishna is an author of 12 book chapters, and numerous peer-reviewed manuscripts. He has presented his work at national and international symposia. His current research centers on stereotactic radiosurgery and radiotherapy and proton treatment for primary and metastastic brain tumors.
Dr. Ramakrishna served for eight years on the faculty of Harvard Medical School as an instructor in radiation oncology. He was also chief of central nervous system radiation oncology at Dana-Farber/Brigham and Women’s Cancer Center and director of the CNS Radiation Oncology Fellowship Program. He is a diplomate of both the United States Medical Licensing Examination and the American Board of Radiology.
Dr. Ramakrishna is an author of 12 book chapters, and numerous peer-reviewed manuscripts. He has presented his work at national and international symposia. His current research centers on stereotactic radiosurgery and radiotherapy and proton treatment for primary and metastastic brain tumors.